Israel approves controversial plan to seize Gaza City, sparking international outcry and domestic opposition.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Melania Trump receives apologies and retractions from James Carville and The Daily Beast over disputed claims about her connection to Jeffrey Epstein.
Israel approves controversial plan to seize Gaza City, sparking international outcry and domestic opposition.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Melania Trump receives apologies and retractions from James Carville and The Daily Beast over disputed claims about her connection to Jeffrey Epstein.